Mobilize Against Malaria (MAM) is Pfizer's signature philanthropic program to combat malaria. MAM is a five-year (2007–2011), $15M initiative announced at the Clinton Global Initiative in 2006, designed to address critical gaps in malaria treatment and education in Ghana, Senegal and Kenya.
The purpose of the MAM Initiative is to reduce malaria morbidity and mortality through the effective delivery of Artemisinin-based Combination Therapy (ACT), the national standard for treating uncomplicated malaria in Ghana, Kenya and Senegal. Each of Pfizer's three MAM programs uses a dual-pronged approach that addresses both the supply of quality public healthcare, as well as communities' demand for treatment. Specifically, MAM aims to:
- Improve malaria symptom recognition, treatment, and referral through targeted training activities
- Support complementary community mobilization campaigns to strengthen the demand for prompt and effective malaria treatment
In each of the three program countries, Pfizer provides support to leading non-governmental organizations (NGO) to implement and evaluate effective malaria interventions. These partners include Family Health International (FHI), Ghana Social Marketing Foundation (GSMF), Health Partners Ghana, Population Services International (PSI), KEMRI-Wellcome Trust and IntraHealth International.
Collaboration with Local and Global Partners
By working with partners on the ground, Pfizer is able to treat, teach, build, and serve communities affected by malaria. Uniquely, Pfizer also supports a multidisciplinary team at the London School of Hygiene and Tropical Medicine (LSHTM) to assist in developing strong and measurable pilot programs with potential for sustainable expansion through other funding organizations. Collaborating with the local implementation partners and evaluators, researchers at LSHTM facilitate the synthesis of cross-cutting issues emerging from the research, which are of strategic importance in the development of regional and global policy agendas on the delivery of health services.
Ghana: Over 1200 Licensed Chemical Sellers (LCS) trained to correctly dose and administer ACTs, and to recognize and refer complicated malaria cases to the nearest health facility in Ashanti Region, Ghana.
Kenya: Over 1600 staff working with pregnant women and young children trained to advise women on prevention and treatment of malaria in Nyanza and Western provinces, Kenya.
Senegal: Community health workers trained in malaria diagnosis and treatment at 24 health huts in Tambacounda, Senegal. All health huts were also equipped with furniture, basic medical and surgical instruments, health management tools, ACTs and notice boards.
The MAM Program in Ghana works with communities in the Ashanti Region to
improve recognition and treatment of malaria. Photo credit: Mark Tushman
- Implementation Report: Lessons Learned from Ghana
- MAM Ghana Documentary
- MAM Senegal Case Study: What Makes a Good Health Hut?
- MAM Senegal Documentary
- Photo Gallery
- MAM Kenya program tools
- Research Publications
- Conference Papers
- Family Health International
- Health Partners International
- Population Services International, Kenya
- KEMRI-Wellcome Trust, Kenya
- IntraHealth International, Dakar, Senegal
- London School of Hygiene and Tropical Medicine